We are live on ! Find out more
INBP

INTEGRATED BIOPHARMA INC.
INBP

Delisted

INBP was delisted on the 26th of February, 2009.

Back to rankings

1 hedge funds and large institutions have $19K invested in INTEGRATED BIOPHARMA INC. in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MSAM
Moloney Securities Asset Management
Missouri
+$19K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MSAM
1
Moloney Securities Asset Management
Missouri
$19K +$19K +20,000 New

INBP Hedge Fund Activity: Q4 2021 in Review

1 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in INTEGRATED BIOPHARMA INC. (INBP) for Q4 2021, worth a combined $19K.

Buyers outnumbered sellers: 1 fund opened new INBP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Moloney Securities Asset Management, opening a new position worth an estimated $19K.

  • 1 institutional investor held INTEGRATED BIOPHARMA INC. (INBP) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $19K of INTEGRATED BIOPHARMA INC. stock for Q4 2021.
  • 1 fund opened new INTEGRATED BIOPHARMA INC. positions in Q4 2021 and 0 closed out, a net change of +1 holder.
  • The largest INTEGRATED BIOPHARMA INC. buyer in Q4 2021 was Moloney Securities Asset Management, an estimated $19K added.

Based on aggregated 13F filings for Q4 2021.